Biotech | January 29, 2022
Israel signs deal to purchase Novavax’ Covid-19 vaccine
It would be the first protein-based alternative available in Israel
It would be the first protein-based alternative available in Israel
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar
It’s a two-dose vaccine administered 28 days apart
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Acute therapies continue to report strong growth compared to chronic ones.
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Subscribe To Our Newsletter & Stay Updated
